Effect of Melatonin supplementation on obesity

Not Applicable

• Conditions: Overweight or obesity.; Obesity

• Registration Number: IRCT2015020120891N1
• Lead Sponsor: ational Nutritional Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

Inclusion criteria (BMI between 25-35; Age between 19 and 55 years)
Exclusion criteria (to be afflicted by thyroid dysfunctions and diabetes mellitus; consumption of drugs affecting body weight and body fat mass; to be afflicted by polycystic ovary syndrome and cushing syndrome; consumption of corticostroids, anti-depresssion drugs, contraceptive drugs, anti convulsion dugs and drugs affecting sleep pattern; consumption of alcohol; to be in the periods of pregnancy or lactation)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body weight. Timepoint: Baseline, 45 days after baseline, 3 months after baseline. Method of measurement: Weighing by weight scale.;Body fat mass percentage. Timepoint: Baseline, 45 days after baseline, 3 months after baseline. Method of measurement: BIA.

Secondary Outcome Measures

Name	Time	Method
Sleep hours. Timepoint: Baseline, 45 days after baseline, 3 months after baseline. Method of measurement: Questionnare.;Salivary Melatonin level. Timepoint: Baseline, 3 months after baseline. Method of measurement: ELISA kit.